Low-Cost Genetic and Clinical Predictors of Response and Toxicity of Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer.
Jelena SpasicMilena ČavićNemanja StanicBojan ZaricTomi KovacevicDavorin RadosavljevicLjudmila Nagorni-ObradovicPublished in: Dose-response : a publication of International Hormesis Society (2022)
A set of easily determined genetic and clinical predictors of survival and specific toxicity profiles of platinum-based chemotherapy in advanced lung adenocarcinoma were determined in this study, which might be useful for the construction of population-specific, time- and cost-efficient prognostic and predictive algorithms.